Bristol Myers Squibb Partners with China's Hengrui Pharma in Multi-Billion Dollar Deal
نظرة سريعة
Bristol Myers Squibb partners with Hengrui Pharma to develop 12 experimental drugs, marking a significant, reciprocal collaboration that could signal increased U.S. pharmaceutical development in China for faster, cheaper drug creation.
ملخص مُنشأ بالذكاء الاصطناعي
Bristol Myers Squibb partners with Hengrui Pharma to develop 12 experimental drugs, marking a significant, reciprocal collaboration that could signal increased U.S. pharmaceutical development in China for faster, cheaper drug creation.






